unknown
Stage
1
Investors
About
ALLOX develops an AI-enabled platform for the systematic discovery of allosteric drug targets to accelerate the development of innovative therapies for previously undruggable proteins, including preclinical development of selective allosteric inhibitors.
Explore ALLOX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.